Stem Cell-Derived Therapy Shows Promise in Progressive Multiple Sclerosis – Neurology Advisor
|
Stem Cell-Derived Therapy Shows Promise in Progressive Multiple Sclerosis
Neurology Advisor VANCOUVER, British Columbia — Intrathecal administration of autologous mesenchymal stem cell-derived neural progenitors (MSC-NPs) was safe and well tolerated as a regenerative multiple sclerosis (MS) therapy, concluded a first-of-its-kind study … |
